版本:
中国

BRIEF-Allergan to buy Vitae Pharmaceuticals for about $639 mln

Sept 14 Allergan Plc

* Allergan to acquire Vitae Pharmaceuticals adding innovative development programs for dermatologic conditions

* Says will acquire Vitae for $21.00 per share, in cash

* Boards of directors of both companies have unanimously approved transaction

* Says total transaction value of approximately $639 million

* Anticipates closing transaction by end of 2016 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐